Royal Philips NV reported first-quarter earnings that surpassed market expectations, driven by robust order performance. The medical technology company demonstrated resilience in the face of geopolitical instability and rising cost pressures. The Amsterdam-listed firm disclosed on Wednesday that its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) for the quarter reached €353 million (equivalent to $414 million), exceeding analysts' forecasts of €322.5 million. The manufacturer of MRI scanners also maintained its full-year outlook for comparable sales growth and adjusted EBITDA margin. Medical imaging equipment producers, including Philips and Siemens Healthineers, have been contending with the impact of U.S. import tariffs. Recent disruptions to shipping routes in the Strait of Hormuz have further exacerbated significant supply chain disturbances, particularly affecting the production and supply of equipment such as CT and MRI scanners.